| Gene symbol | tk |
| GTO ID | GTC1136 |
| Trial ID | NCT00001328 |
| Disease | Brain Neoplasm |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | rv.HSV-TK |
| Co-treatment | Cytovene (Ganciclovir Sodium) |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction With the Thymidine Kinase Gene and Intravenous Ganciclovir |
| Year | 1999 |
| Country | United States |
| Company sponsor | Massachusetts Eye/Ear Infirmary|Harvard Medical School |
| Other ID(s) | 920246|92-N-0246 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||